期刊文献+

某院新生儿科抗菌药物的药事干预

Pharmaceutical Intervention on the use of Antibiotics in the Neonatology of X-hospital
下载PDF
导出
摘要 目的某院药剂科通过对该院新生儿科抗菌药物地使用进行药事干预,促进新生儿科抗菌药物的合理使用。方法采集干预前和干预后某院新生儿科出院患者的抗菌药物使用率等数据,进行分析对比,了解干预的效果。结果干预前和干预后出院患者抗菌药物使用率分别是96.9%、76.4%,干预前后新生儿高胆红素血症的抗菌药物使用率分别是93.6%、56.8%,干预前后新生儿溶血症的抗菌药物使用率分别是100%、52.1%。结论通过药剂科对该院新生儿科抗菌药物使用的药事干预,新生儿科出院患者抗菌药物使用率明显下降,抗菌药物地使用趋向合理,这种干预方法能很好地引导临床合理用药。 Objective Through the pharmaceutical intervention on the use of antibiotics in the neonatology of X-hospital,to promote rational use of antibiotics. Methods From collecting, analyzing,and comparing the neonatal antibiotics usage data of patients discharged from X-hospital before the intervention and post-intervention, to get the message of the effect of the intervention. Results The neonatal antibiotics usage ratios of patients discharged from X-hospital before the intervention and post-intervention were 96.9% and 76.4% respectively; the neonatal antibiotics usage ratios of hyperbilirubinmia in newborns before the intervention and post-intervention were 93.6%, 56.8%, the neonatal antibiotics usage ratios of hemolytic disease of newborn before the intervention and post-intervention were100%, 52.1%. Conclusion Through the pharmaceutical intervention on the use of antibiotics in the neonatology,the using of antibiotics in Neonatology discharged patients decreased significantly,which was tend to be reasonable.This intervention can be a good guide of using antibiotics rationally.
出处 《中国卫生产业》 2015年第16期12-14,共3页 China Health Industry
关键词 新生儿科 抗菌药物使用率 新生儿高胆红素血症 新生儿溶血症 Neonatology The usage ratios of antibiotics Hyperbilirubinemia of newborn Hemolytic disease of newborn
  • 相关文献

参考文献5

二级参考文献45

  • 1杜东红,王俐.新生儿脓毒症病原菌及其耐药性分析[J].实用医院临床杂志,2010,7(4):122-123. 被引量:1
  • 2顾群,吴辰,李玉珍.住院患者抗菌药物使用调查与分析[J].中华医院感染学杂志,2007,17(3):314-316. 被引量:25
  • 3金汉珍 黄德珉 官希吉.实用新生儿学[M].北京:人民卫生出版社,2001.1034.
  • 4钱红兰,胡旭东,沈志坚,陈怡,孙岚,张君丽.非霍奇金淋巴瘤患者医院感染临床及病原体分析[J].温州医学院学报,2007,37(5):485-487. 被引量:3
  • 5Baltimore RS, Huie SM, MeekJI, et al. Early-onset neonatal sepsis in the era of group B streptococcal prevention[J]. Pediatrics, 2001, 108 (5) : 1094-1098.
  • 6CDC. Diminishing racial disparities in early-onset neonatal group B streptococcal disease-United States, 2000 - 2003[J]. MMWR Morb Mortal Wkly Rep, 2004, 53 (23) : 502-505.
  • 7McCracken G . Group B streptococci: the new challenge in neonatal infections[J]. TheJournal of pediatrics, 1973,82(4): 703-706.
  • 8Labenne M, Michaut F, Gouyon B, et al. A population-based observational study of restrictive guidelines for antibiotic therapy in early-onset neonatal infections[J]. Pediatr Infect DisJ, 2007, 26 (7) : 593-599.
  • 9Faust S. New therapies for treating infections in infants and children[J]. Current Paediatrics, 2004, 14(2): 122-130.
  • 10Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002 - 2003[J]. Pediatr Infect DisJ, 2005, 24 (7) : 635-639.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部